Life Science Investing NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO 10 December 2025
Life Science Investing NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO 03 December 2025
Life Science Investing NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward 20 November 2025
